{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:34:55Z","timestamp":1787240095007,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s40261-016-0440-9","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T07:24:31Z","timestamp":1469085871000},"page":"771-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Loxoprofen: A Review in Pain and Inflammation"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-8377","authenticated-orcid":false,"given":"Sarah L.","family":"Greig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly P.","family":"Garnock-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"issue":"5","key":"440_CR1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester G, Lanas A, Biasucci L, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011;70(5):818\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"440_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"440_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000211713","volume":"79","author":"T Arakawa","year":"2009","unstructured":"Arakawa T, Fujiwara Y, Sollano JD, et al. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79(3):177\u201385.","journal-title":"Digestion."},{"key":"440_CR4","first-page":"1061","volume":"11","author":"N Moore","year":"2015","unstructured":"Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061\u201375.","journal-title":"Ther Clin Risk Manag"},{"key":"440_CR5","doi-asserted-by":"crossref","unstructured":"Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis\u2014an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13:[article no. 55].","DOI":"10.1186\/s12916-015-0285-8"},{"issue":"1","key":"440_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MCG.0000000000000432","volume":"50","author":"JM Scheiman","year":"2016","unstructured":"Scheiman JM. NSAID-induced gastrointestinal injury: a focused update for clinicians. J Clin Gastroenterol. 2016;50(1):5\u201310.","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"440_CR7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634\u201342.","journal-title":"Circulation"},{"issue":"4 Suppl","key":"440_CR8","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","volume":"45","author":"F Rannou","year":"2016","unstructured":"Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S18\u201321.","journal-title":"Semin Arthritis Rheum"},{"issue":"4 Suppl","key":"440_CR9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.semarthrit.2015.11.010","volume":"45","author":"O Bruy\u00e8re","year":"2016","unstructured":"Bruy\u00e8re O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis\u2014from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3\u201311.","journal-title":"Semin Arthritis Rheum"},{"key":"440_CR10","unstructured":"Daiichi Sankyo Co Ltd. Loxonin\u00ae Pap 100 mg, Tape 50 mg and 100 mg (loxoprofen sodium hydrate patches): Japanese interview form on drugs. 2015. http:\/\/www.pmda.go.jp . Accessed 8 Jan 2016."},{"key":"440_CR11","unstructured":"Daiichi Sankyo Co Ltd. Loxoprofen sodium tablets: Chinese prescribing information. 2009. http:\/\/www.daiichisankyo.com.cn . Accessed 2 Mar 2016."},{"key":"440_CR12","unstructured":"Daiichi Sankyo Co Ltd. Loxoprofen patches: Chinese prescribing information. 2015. http:\/\/www.daiichisankyo.com.cn . Accessed 2 Mar 2016."},{"key":"440_CR13","unstructured":"Daiichi Sankyo Co Ltd. Loxonin\u00ae Pap 100 mg, Tape 50 mg and 100 mg, Gel 1\u00a0%: Japanese summarized product information. 2014."},{"key":"440_CR14","first-page":"1","volume":"36","author":"K Tanaka","year":"1984","unstructured":"Tanaka K, Terada A, Iizuka Y, et al. Loxoprofen sodium (CS-600), a new non-steroidal anti-inflammatory drug. Ann Rep Sankyo Res Lab. 1984;36:1\u201343.","journal-title":"Ann Rep Sankyo Res Lab."},{"issue":"11","key":"440_CR15","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1248\/bpb.28.2075","volume":"28","author":"M Noguchi","year":"2005","unstructured":"Noguchi M, Kimoto A, Gierse JK, et al. Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites. Biol Pharm Bull. 2005;28(11):2075\u20139.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"440_CR16","first-page":"179","volume":"22","author":"T Hamamoto","year":"2006","unstructured":"Hamamoto T, Takeuchi S, Sasakura M, et al. Anti-inflammatory and analgesic effects of hydrogel patches containing loxoprofen sodium [Japanese with English abstract]. J Clin Ther Med. 2006;22(3):179\u201386.","journal-title":"J Clin Ther Med."},{"issue":"3","key":"440_CR17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10157-013-0850-4","volume":"18","author":"H Araki","year":"2014","unstructured":"Araki H, Kuwagata S, Soumura M, et al. Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy. Clin Exp Nephrol. 2014;18(3):487\u201391.","journal-title":"Clin Exp Nephrol."},{"issue":"1","key":"440_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1746.1995.tb01053.x","volume":"10","author":"S Kawano","year":"1995","unstructured":"Kawano S, Tsuji S, Hayashi N, et al. Effects of loxoprofen sodium, a newly synthesized non-steroidal anti-inflammatory drug, and indomethacin on gastric mucosal haemodynamics in the human. J Gastroenterol Hepatol. 1995;10(1):81\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"440_CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1443-1661.2012.01379.x","volume":"25","author":"K Mizukami","year":"2013","unstructured":"Mizukami K, Murakami K, Yamauchi M, et al. Evaluation of selective cyclooxygenase-2 inhibitor-induced small bowel injury: randomized cross-over study compared with loxoprofen in healthy subjects. Dig Endosc. 2013;25(3):288\u201394.","journal-title":"Dig Endosc."},{"issue":"3","key":"440_CR20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.12174","volume":"37","author":"C Sakamoto","year":"2013","unstructured":"Sakamoto C, Kawai T, Nakamura S, et al. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study. Aliment Pharmacol Ther. 2013;37(3):346\u201354.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"440_CR21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MCG.0000000000000372","volume":"50","author":"S Fujimori","year":"2016","unstructured":"Fujimori S, Hanada R, Hayashida M, et al. Celecoxib monotherapy maintained small intestinal mucosa better compared with loxoprofen plus lansoprazole treatment: a double-blind, randomized, controlled trial. J Clin Gastroenterol. 2016;50(3):218\u201326.","journal-title":"J Clin Gastroenterol"},{"key":"440_CR22","unstructured":"Daiichi Sankyo Co Ltd. Loxonin\u00ae (loxoprofen sodium) tablets 60 mg, fine granules 10\u00a0%: Japanese interview form on drugs. 2014. http:\/\/www.info.pmda.go.jp . Accessed 18 May 2016."},{"issue":"4","key":"440_CR23","first-page":"279","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Hasegawa S, Naganuma H, et al. Pharmacokinetic study of the hydrogel patch containing loxoprofen sodium (LX-A) following 5 days applications repeated once or twice a day [Japanese with English abstract]. J Clin Ther Med. 2006;22(4):279\u201392.","journal-title":"J Clin Ther Med."},{"issue":"10","key":"440_CR24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5414\/CP202165","volume":"52","author":"X Chen","year":"2014","unstructured":"Chen X, Zhao Q, Hitsu E, et al. Dermatopharmacokinetic bioequivalence study of two types of topical patches containing loxoprofen sodium. Int J Clin Pharmacol Ther. 2014;52(10):927\u201332.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"440_CR25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5414\/CP202281","volume":"53","author":"X Chen","year":"2015","unstructured":"Chen X, Matsuzawa T, Hitsu E, et al. Model of the dermatopharmacokinetic profile of two loxoprofen patches for bioequivalence confirmation. Int J Clin Pharmacol Ther. 2015;53(5):412\u20133.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"440_CR26","first-page":"187","volume":"22","author":"T Matsuzawa","year":"2006","unstructured":"Matsuzawa T, Sairo H, Kurihara A, et al. Absorption, distribution, metabolism and excretion after dermal application of hydrogel patch containing loxoprofen sodium in rats [Japanese with English abstract]. J Clin Ther Med. 2006;22(3):187\u2013203.","journal-title":"J Clin Ther Med."},{"issue":"2","key":"440_CR27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jos.2015.11.005","volume":"21","author":"A Onda","year":"2016","unstructured":"Onda A, Ogoshi A, Itoh M, et al. Comparison of the effects of treatment with celecoxib, loxoprofen, and acetaminophen on postoperative acute pain after arthroscopic knee surgery: a randomized, parallel-group trial. J Orthop Sci. 2016;21(2):172\u20137.","journal-title":"J Orthop Sci."},{"issue":"4","key":"440_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00776-015-0726-4","volume":"20","author":"H Sekiguchi","year":"2015","unstructured":"Sekiguchi H, Inoue G, Nakazawa T, et al. Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study. J Orthop Sci. 2015;20(4):617\u201323.","journal-title":"J Orthop Sci."},{"issue":"1","key":"440_CR29","first-page":"46","volume":"4","author":"Y-Q Shi","year":"2004","unstructured":"Shi Y-Q, Han X-H. Clinical observation of loxoprofen sodium in treatment of patients with knee osteoarthritis [Chinese with English abstract]. Pharm Care Res. 2004;4(1):46\u20138.","journal-title":"Pharm Care Res."},{"issue":"1","key":"440_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00044011-199510010-00010","volume":"10","author":"S Waikakul","year":"1995","unstructured":"Waikakul S, Soparat K. Effectiveness and safety of loxoprofen compared with naproxen in nonsurgical low back pain: a parallel study. Clin Drug Investig. 1995;10(1):59\u201363.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"440_CR31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/14397595.2013.852857","volume":"24","author":"S Ohta","year":"2014","unstructured":"Ohta S, Komai O, Hanakawa H. Comparative study of the clinical efficacy of the selective cyclooxygenase-2 inhibitor celecoxib compared with loxoprofen in patients with frozen shoulder. Mod Rheumatol. 2014;24(1):144\u20139.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"440_CR32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03259212","volume":"4","author":"T Aoki","year":"1992","unstructured":"Aoki T. Effectiveness and safety of loxoprofen in elderly patients with lumbar pain. Drug Invest. 1992;4(6):477\u201383.","journal-title":"Drug Invest."},{"issue":"4","key":"440_CR33","first-page":"293","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Tateishi A, Tanaka M, et al. A dose finding study of a hydrogel patch containing loxoprofen sodium (LX-A) in patients with osteoarthritis of the knee (late phase II clinical study): a randomized, double-blind, placebo controlled comparative study [Japanese with English abstract]. J Clin Ther Med. 2006;22(4):293\u2013310.","journal-title":"J Clin Ther Med."},{"issue":"4","key":"440_CR34","first-page":"311","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Tateishi A, Tanaka M, et al. Evaluation of administration frequency of LX-A in patients with osteoarthritis of the knee: randomized, open label study compared between once-daily administration and twice-daily administration [Japanese with English abstract]. J Clin Ther Med. 2006;22(4):311\u201326.","journal-title":"J Clin Ther Med."},{"issue":"1","key":"440_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10067-014-2701-4","volume":"35","author":"R Mu","year":"2016","unstructured":"Mu R, Bao CD, Chen ZW, et al. Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clin Rheumatol. 2016;35(1):165\u201373.","journal-title":"Clin Rheumatol"},{"key":"440_CR36","unstructured":"Zhao DB, Shi YQ, Li ZG, et al. Effectiveness and safety of hydrogel patches containing loxoprofen sodium in patients with myalgia: a randomized, controlled, double-blind, double-parallel, multicenter phase 3 trial [abstract no. APLAR-0134]. Int J Rheum Dis. 2013;16(Suppl 1):111."},{"key":"440_CR37","unstructured":"Zhang H, Lin J, Sun T, et al. Double-blind, multicenter trial to evaluate safety and efficacy of hydrogel patch containing loxoprofen-sodium in treating swelling and pain caused by trauma [abstract no. APLAR-0153]. Int J Rheum Dis. 2013;16(Suppl 1):111."},{"issue":"5","key":"440_CR38","first-page":"393","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Kuroki Y, Tateishi A, et al. The effects of Loxonin\u00ae Pap 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of patients with osteoarthritis of the knee: randomized, double-blind clinical study with loxoprofen sodium tablets [Japanese with English abstract]. J Clin Ther Med. 2006;22(5):393\u2013409.","journal-title":"J Clin Ther Med."},{"issue":"5","key":"440_CR39","first-page":"411","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Kuroki Y, Tanaka M, et al. The effects of Loxonin\u00ae Pap 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of myalgia: randomized, double-blind study compared with loxoprofen sodium tablets [Japanese with English abstract]. J Clin Ther Med. 2006;22(5):411\u201326.","journal-title":"J Clin Ther Med."},{"issue":"5","key":"440_CR40","first-page":"427","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Iwasaki Y, Aoki T. The effects of Loxonin\u00ae Pap 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of swelling or pain following injuries: randomized, double-blind study with loxoprofen sodium tablets [Japanese with English abstract]. J Clin Ther Med. 2006;22(5):427\u201342.","journal-title":"J Clin Ther Med."},{"issue":"1","key":"440_CR41","first-page":"55","volume":"23","author":"S Sugawara","year":"2007","unstructured":"Sugawara S, Nobuoka F, Ogawa D, et al. Clinical efficacy of the hydrogel patch containing loxoprofen sodium (LX-A) on osteoarthritis of the knee: a randomized, open label clinical study with ketoprofen patch (phase III therapeutic confirmatory study) [Japanese with English abstract]. J Clin Ther Med. 2007;23(1):55\u201371.","journal-title":"J Clin Ther Med."},{"issue":"2","key":"440_CR42","first-page":"127","volume":"23","author":"S Sugawara","year":"2007","unstructured":"Sugawara S, Nobuoka F, Ogawa D, et al. Clinical efficacy of the hydrogel patch containing loxoprofen sodium (LX-A) on myalgia: a randomized, open label clinical study compared with indometacin patch (phase III therapeutic confirmatory study) [Japanese with English abstract]. J Clin Ther Med. 2007;23(2):127\u201341.","journal-title":"J Clin Ther Med."},{"issue":"10","key":"440_CR43","first-page":"727","volume":"26","author":"H Mizutani","year":"2010","unstructured":"Mizutani H, Miyano F, Uozu A, et al. Drug use result survey of Loxonin\u00ae Tape (patch containing loxoprofen sodium hydrate) [Japanese with English abstract]. J Clin Ther Med. 2010;26(10):727\u201341.","journal-title":"J Clin Ther Med."},{"issue":"3","key":"440_CR44","first-page":"227","volume":"26","author":"H Mizutani","year":"2010","unstructured":"Mizutani H, Miyano F, Uozu A, et al. Drug use result survey of Loxonin\u00ae Pap (hydrogel patch containing loxoprofen sodium hydrate) [Japanese with English abstract]. J Clin Ther Med. 2010;26(3):227\u201340.","journal-title":"J Clin Ther Med."},{"issue":"1","key":"440_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1757-7861.2009.00055.x","volume":"2","author":"Chinese Orthopaedic Association","year":"2010","unstructured":"Chinese Orthopaedic Association. Diagnosis and treatment of osteoarthritis. Orthop Surg. 2010;2(1):1\u20136.","journal-title":"Orthop Surg."},{"issue":"1\u20132","key":"440_CR46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000318746","volume":"83","author":"C Sakamoto","year":"2011","unstructured":"Sakamoto C, Soen S. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion. 2011;83(1\u20132):108\u201323.","journal-title":"Digestion."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0440-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0440-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:54:41Z","timestamp":1498316081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0440-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0440-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}